NARDONE, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 2.051
EU - Europa 1.844
AS - Asia 329
OC - Oceania 4
Totale 4.228
Nazione #
US - Stati Uniti d'America 2.048
GB - Regno Unito 702
IE - Irlanda 407
CN - Cina 205
IT - Italia 168
UA - Ucraina 140
SE - Svezia 135
DE - Germania 82
FR - Francia 69
RU - Federazione Russa 42
VN - Vietnam 37
FI - Finlandia 31
TR - Turchia 31
ES - Italia 29
IN - India 26
BE - Belgio 18
SG - Singapore 18
IR - Iran 8
IM - Isola di Man 7
AU - Australia 4
RO - Romania 4
CA - Canada 3
MK - Macedonia 3
AT - Austria 2
BD - Bangladesh 2
HK - Hong Kong 2
PL - Polonia 2
GR - Grecia 1
LT - Lituania 1
NL - Olanda 1
Totale 4.228
Città #
Southend 654
Dublin 400
Fairfield 315
Chandler 184
Ashburn 151
Woodbridge 144
Ann Arbor 136
Wilmington 130
Jacksonville 117
Seattle 112
Houston 100
Menlo Park 99
Cambridge 93
Siena 74
Beijing 55
New York 52
Princeton 46
Dearborn 37
Dong Ket 37
Fremont 30
Izmir 30
Málaga 29
Nanjing 29
Shanghai 21
Helsinki 20
Brussels 18
Boardman 17
Florence 15
San Mateo 15
Singapore 14
San Diego 13
Munich 11
Shenyang 11
Tianjin 11
Moscow 9
Nanchang 9
Douglas 7
Falls Church 7
Hebei 7
Jiaxing 7
Kunming 7
Changsha 6
Zanjan 6
Zhengzhou 6
Fort Worth 5
Massa 5
Phoenix 5
Sacramento 5
Fuzhou 4
Guangzhou 4
Hangzhou 4
Jinan 4
Milan 4
Ningbo 4
Reggio Calabria 4
Timisoara 4
Buffalo 3
Henderson 3
Hounslow 3
Lancaster 3
Mumbai 3
Redwood City 3
San Vitaliano 3
Skopje 3
Bari 2
Bhopal 2
Dallas 2
Delhi 2
Dhaka 2
Duncan 2
Falkenstein 2
Hong Kong 2
Islington 2
Kilburn 2
Lanzhou 2
London 2
Priocca 2
Rome 2
Santa Clara 2
Sezze 2
Taizhou 2
Tehran 2
Turin 2
Vienna 2
Vijayawada 2
Wuhan 2
Adelaide 1
Aigaleo 1
Airdrie 1
Amsterdam 1
Asciano 1
Bangalore 1
Borghetto Lodigiano 1
Brainerd 1
Campi Bisenzio 1
Canberra 1
Carraia 1
Caserta 1
Cessaniti 1
Changchun 1
Totale 3.425
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 241
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 234
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 212
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 203
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 193
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 181
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 176
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 153
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 153
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 148
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 146
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 146
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 143
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 143
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 141
null 139
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 138
null 130
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 128
null 126
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 126
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 117
null 117
null 116
null 82
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 81
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 62
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 49
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 49
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 45
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 42
In Regard to Kubicek et al. 40
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 33
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 32
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 29
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 23
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 15
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma 10
Totale 4.342
Categoria #
all - tutte 12.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020842 0 27 62 111 61 95 93 112 100 95 37 49
2020/2021753 35 81 18 67 56 94 39 99 59 94 27 84
2021/2022444 29 56 35 17 31 26 29 27 30 44 46 74
2022/2023642 31 62 92 77 64 120 19 54 60 36 14 13
2023/2024600 16 10 58 30 17 169 264 3 5 8 4 16
2024/202565 31 34 0 0 0 0 0 0 0 0 0 0
Totale 4.342